Page 1 | Search Results | Hematology, ASH Education Program

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Indolent lymphomas: pushing the pace with novel agents

Caron A. Jacobson

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 279–286.

https://doi.org/10.1182/hematology.2019000032

Published: 2019

Journal Articles

Molecular profiling and management of mantle cell lymphoma

Jia Ruan

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 30–40.

https://doi.org/10.1182/hematology.2019000011

Published: 2019

Journal Articles

Where does transplant fit in the age of targeted therapies?

Victor A. Chow, Ajay K. Gopal

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 287–293.

https://doi.org/10.1182/hematology.2019000033

Published: 2019

Journal Articles

How I treat a refractory myeloma patient who is not eligible for a clinical trial

Siyang Leng, Divaya Bhutani, Suzanne Lentzsch

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 125–136.

https://doi.org/10.1182/hematology.2019000016

Published: 2019

Journal Articles

Optimizing frontline therapy of CLL based on clinical and biological factors

Kirsten Fischer, Michael Hallek

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 338–345.

https://doi.org/10.1182/asheducation-2017.1.338

Published: 2017

Journal Articles

Optimizing therapy for mantle cell lymphoma

Peter Martin

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 304–309.

https://doi.org/10.1182/asheducation-2017.1.304

Published: 2017

Journal Articles

Prognostic factors in follicular lymphoma: new tools to personalize risk

Carla Casulo

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 269–276.

https://doi.org/10.1182/asheducation-2016.1.269

Published: 2016

Journal Articles

Management of prolymphocytic leukemia

Claire Dearden

Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 361–367.

https://doi.org/10.1182/asheducation-2015.1.361

Published: 2015

Journal Articles

Management of symptoms in polycythemia vera and essential thrombocythemia patients

Deepti Radia, Holly L. Geyer

Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 340–348.

https://doi.org/10.1182/asheducation-2015.1.340

Published: 2015

Journal Articles

What is the role of autologous transplant for lymphoma in the current era?

Patrick Stiff

Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 74–81.

https://doi.org/10.1182/asheducation-2015.1.74

Published: 2015

Journal Articles

Diagnosis and management of mastocytosis: an emerging challenge in applied hematology

Peter Valent

Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 98–105.

https://doi.org/10.1182/asheducation-2015.1.98

Published: 2015

Journal Articles

Hepatitis C virus-associated B-cell non-Hodgkin lymphomas

Barbara Vannata, Emanuele Zucca

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 590–598.

https://doi.org/10.1182/asheducation-2014.1.590

Published: 2014

Journal Articles

Lymphocyte-predominant Hodgkin lymphoma: what is the optimal treatment?

Michelle Fanale

Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 406–413.

https://doi.org/10.1182/asheducation-2013.1.406

Published: 2013

Journal Articles

The many faces of marginal zone lymphoma

Pier Luigi Zinzani

Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 426–432.

https://doi.org/10.1182/asheducation.V2012.1.426.3798535

Published: 2012

Journal Articles

Current treatment standards and emerging strategies in mantle cell lymphoma

Martin Dreyling, Wolfgang Hiddemann, for The European MCL Network

Hematology Am Soc Hematol Educ Program (2009) 2009 (1): 542–551.

https://doi.org/10.1182/asheducation-2009.1.542

Published: 2009

Journal Articles

Marginal Zone Lymphomas: Management of Nodal, Splenic, and MALT NHL

Brad Kahl, David Yang

Hematology Am Soc Hematol Educ Program (2008) 2008 (1): 359–364.

https://doi.org/10.1182/asheducation-2008.1.359

Published: 2008

Journal Articles

Reduced-Intensity Stem Cell Transplantation: “...whereof a little More than a little is by much too much.” King Henry IV, part 1, I, 2

Joseph H. Antin

Hematology Am Soc Hematol Educ Program (2007) 2007 (1): 47–54.

https://doi.org/10.1182/asheducation-2007.1.47

Published: 2007

Journal Articles

Hematopathology Approaches to Diagnosis and Prognosis of Indolent B-Cell Lymphomas

Randy D. Gascoyne

Hematology Am Soc Hematol Educ Program (2005) 2005 (1): 299–306.

https://doi.org/10.1182/asheducation-2005.1.299

Published: 2005

Journal Articles

Clinical Presentation and Management of Marginal Zone Lymphomas

Catherine Thieblemont

Hematology Am Soc Hematol Educ Program (2005) 2005 (1): 307–313.

https://doi.org/10.1182/asheducation-2005.1.307

Published: 2005

Journal Articles

Biology and Treatment of Chronic Lymphocytic Leukemia

Michael J. Keating, Nicholas Chiorazzi, Bradley Messmer, Rajendra N. Damle, Steven L. Allen, Kanti R. Rai, Manlio Ferrarini, Thomas J. Kipps

Hematology Am Soc Hematol Educ Program (2003) 2003 (1): 153–175.

https://doi.org/10.1182/asheducation-2003.1.153

Published: 2003

NARROW

Indolent lymphomas: pushing the pace with novel agents

Molecular profiling and management of mantle cell lymphoma

Where does transplant fit in the age of targeted therapies?

How I treat a refractory myeloma patient who is not eligible for a clinical trial

Optimizing frontline therapy of CLL based on clinical and biological factors

Optimizing therapy for mantle cell lymphoma

Prognostic factors in follicular lymphoma: new tools to personalize risk

Management of prolymphocytic leukemia

Management of symptoms in polycythemia vera and essential thrombocythemia patients

What is the role of autologous transplant for lymphoma in the current era?

Diagnosis and management of mastocytosis: an emerging challenge in applied hematology

Hepatitis C virus-associated B-cell non-Hodgkin lymphomas

Lymphocyte-predominant Hodgkin lymphoma: what is the optimal treatment?

The many faces of marginal zone lymphoma

Current treatment standards and emerging strategies in mantle cell lymphoma

Marginal Zone Lymphomas: Management of Nodal, Splenic, and MALT NHL

Reduced-Intensity Stem Cell Transplantation: “...whereof a little More than a little is by much too much.” King Henry IV, part 1, I, 2

Hematopathology Approaches to Diagnosis and Prognosis of Indolent B-Cell Lymphomas

Clinical Presentation and Management of Marginal Zone Lymphomas

Biology and Treatment of Chronic Lymphocytic Leukemia

ASH Publications

American Society of Hematology

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only